Basics Humacyte, Inc. Common Stock IPO Date: November 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $220.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 3.86% Avg Daily Range (30 D): $0.04 | 3.34% Avg Daily Range (90 D): $0.06 | 4.02% Institutional Daily Volume Avg Daily Volume: 1.75M Avg Daily Volume (30 D): 4.53M Avg Daily Volume (90 D): 4.85M Trade Size Avg Trade Size (Sh.): 194 Avg Trade Size (Sh.) (30 D): 386 Avg Trade Size (Sh.) (90 D): 370 Institutional Trades Total Inst.Trades: 303 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $2.37M Avg Inst. Trade (90 D): $2.89M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $2.37M Avg Closing Trade (90 D): $4.94M Avg Closing Volume: 342.55K     News Dec 22, 2025 @ 1:00 PM Humacyte Announces Publication of Long-Term Safety... Source: Na Nov 12, 2025 @ 4:00 PM Strong Earnings and Biotech Resilience Define the ... Source: Na Sep 18, 2025 @ 7:08 PM Russell 2000 Hits All-Time Highs: 8 Stocks Power S... Source: Piero Cingari Aug 11, 2025 @ 11:20 AM Humacyte Posts Q2 Revenue Miss Source: Jesterai Mar 26, 2025 @ 10:18 AM US Stocks Likely To Open Lower After 3-Day Advance... Source: Rishabh Mishra Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.27 $-.11 $-.24 Diluted EPS $-.27 $-.11 $-.24 Revenue $ 1.57M $ .75M $ .3M Gross Profit $ $ .49M $ .09M Net Income / Loss $ -36.97M $ -17.51M $ -37.66M Operating Income / Loss $ -105.39M $ -24.39M $ -29.73M Cost of Revenue $ $ .26M $ .21M Net Cash Flow $ -51.08M $ -68.54M $ -24.82M PE Ratio